Disrupting pathogen virulence
Bactolife
Developing innovative solutions meeting the global need for reducing antimicrobial resistance
Changing the paradigm on
treatment of infectious diseases
Antimicrobial resistance development is a major and increasing threat to human health worldwide
Discover more
precision engineering of microbiomes
Our products are based on minimizing the risk of disease through reduction of virulence, making pathogens unable to establish an active infection
Discover more
Strengthening the healthy gut microbiome in piglets and reducing the risk of post weaning diarrhea in piglets
Discover more
Ablacto+
disrupting pathogen virulence
GUDP Ablacto+ project
Operational strength by strong collaboration and knowledge sharing
Discover more
